Mean platelet volume is associated with aortic arterial stiffness in patients with Behçet's disease without significant cardiovascular involvement

Behçet's disease (BD), is a chronic, systemic vasculitis, which may affect all types and sizes of blood vessels. BD is associated with endothelial dysfunction and chronic inflammation. Endothelial dysfunction is the critical early step in the process of atherogenesis, and it is commonly investigated by measuring arterial stiffness. Mean platelet volume (MPV) has been investigated in relation with both thrombosis and inflammation. We aimed to investigate the relationship between an increased arterial stiffness and MPV in patients with Behçet's disease without significant cardiovascular involvement.

[1]  T. Celik,et al.  Mean platelet volume as a surrogate marker of low-grade inflammation in osteoarthritis , 2014, Platelets.

[2]  T. Celik,et al.  Carotid Intima-Media Thickness in Patients With Slow Coronary Flow and Its Association With Neutrophil-to-Lymphocyte Ratio , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[3]  C. Ergin,et al.  Mean Platelet Volume in Recurrent Aphthous Stomatitis and Behçet Disease , 2014, Angiology.

[4]  T. Celik,et al.  Aortic Arterial Stiffness is a Moderate Predictor of Cardiovascular Disease in Patients With Psoriasis Vulgaris , 2014, Angiology.

[5]  T. Çaycı,et al.  Carotid Intima Media Thickness and Its Association With Total Bilirubin Levels in Patients With Coronary Artery Ectasia , 2020, Angiology.

[6]  Ş. Balta,et al.  Peripheral arterial disease in patients with Behçet’s disease , 2014, Rheumatology International.

[7]  T. Celik,et al.  Association Between Coronary Artery Ectasia and Neutrophil–Lymphocyte Ratio , 2013, Angiology.

[8]  Ş. Balta,et al.  Mean platelet volume may be related to the degree of coronary collateral circulation. , 2013, European review for medical and pharmacological sciences.

[9]  H. Falet.  New insights into the versatile roles of platelet FlnA , 2013, Platelets.

[10]  F. España,et al.  Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Behçet's disease. , 2013, Clinical hemorheology and microcirculation.

[11]  Ş. Balta,et al.  Red cell distribution width: a novel inflammatory marker in clinical practice. , 2013, Cardiology journal.

[12]  Ü. Türsen.  Pathophysiology of the Behçet's Disease , 2011, Pathology research international.

[13]  G. Kitas,et al.  Mean platelet volume: a link between thrombosis and inflammation? , 2011, Current pharmaceutical design.

[14]  N. Ermis,et al.  Increased mean platelet volume in Behçet's disease with thrombotic tendency. , 2010, The Tohoku journal of experimental medicine.

[15]  G. Vaiopoulos,et al.  Etiopathogenesis of Behçet's disease with emphasison the role of immunological aberrations , 2010, Clinical Rheumatology.

[16]  Deepak L. Bhatt,et al.  Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis , 2010, Journal of thrombosis and haemostasis : JTH.

[17]  S. Köklü,et al.  An overlooked indicator of disease activity in ulcerative colitis: Mean platelet volume , 2009, Platelets.

[18]  Jong Chun Park,et al.  Carotid artery intima-media thickness in Behcet's disease patients without significant cardiovascular involvement , 2008, The Korean journal of internal medicine.

[19]  S. Oktar,et al.  Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet’s disease , 2008, Clinical Rheumatology.

[20]  M. Rhee,et al.  Intima-media Thickness and Arterial Stiffness of Carotid Artery in Korean Patients with Behçet's Disease , 2007, Journal of Korean medical science.

[21]  S. Akar,et al.  Circulated Activated Platelets and Increased Platelet Reactivity in Patients With Behçet’s Disease , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[22]  M. Rhee,et al.  Arterial stiffness in Behçet’s disease: increased regional pulse wave velocity values , 2006, Annals of the rheumatic diseases.

[23]  M. Kayıkçıoğlu,et al.  Endothelial functions in Behçet’s disease , 2006, Rheumatology International.

[24]  H. Oflaz,et al.  Impaired endothelium‐dependent flow‐mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement , 2005, International journal of clinical practice.

[25]  T. Celik,et al.  Angioplasty to the Axillo-Axillary By-Pass Graft in a Patient with Behçet's Disease - , 2005 .

[26]  N. Ermis,et al.  Vascular endothelial function and plasma homocysteine levels in Behcet's disease. , 2004, The American journal of cardiology.

[27]  J. Lekakis,et al.  Aortic elastic properties and left ventricular diastolic function in patients with Adamantiades-Behcet's disease. , 2004, Journal of the American College of Cardiology.

[28]  Y. Turkoz,et al.  Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome , 2003, International journal of dermatology.

[29]  I. Haznedaroglu,et al.  Pathological haemostasis and "prothrombotic state" in Behçet's disease. , 2002, Thrombosis research.

[30]  David J. Webb,et al.  Nitric Oxide Regulates Local Arterial Distensibility In Vivo , 2002, Circulation.

[31]  Mark A. Creager,et al.  Endothelium-Derived Nitric Oxide Regulates Arterial Elasticity in Human Arteries In Vivo , 2001, Hypertension.

[32]  B. Altun,et al.  Interactions of nitric oxide and superoxide dismutase in Behçet's disease. , 2001, Clinical and experimental rheumatology.

[33]  Ş. Kirazlı,et al.  Selectin adhesion molecules in Behçet's disease , 2000, Annals of the rheumatic diseases.

[34]  O. Ozcebe,et al.  Behçet's disease. , 2019, The New England journal of medicine.

[35]  N. Sayınalp,et al.  Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease. , 1999, Rheumatology international.

[36]  N. Sayınalp,et al.  Effects of interferon-α2a treatment on serum levels of tumor necrosis factor-α, tumor necrosis factor-α2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease , 1999, Rheumatology International.

[37]  A. Silman,et al.  [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.